Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06993142Not ApplicableNot Yet Recruiting

Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage

Role: collaborator

NCT06193252Not ApplicableRecruiting

Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands

Role: collaborator

NCT05806775Not ApplicableCompleted

Low-load Resistance Training With Blood Flow Restriction in People With Parkinson's Disease

Role: collaborator

NCT05464225Not ApplicableCompleted

Colorado Oral Strengthening Device

Role: collaborator

NCT02538029Not ApplicableCompleted

The Effects of Dual Task Training in Individuals With Parkinson's Disease

Role: collaborator

NCT02144220Not ApplicableCompleted

Remote Access to Care, Everywhere, for Parkinson Disease

Role: collaborator

All 6 trials loaded